ConductScience.org, home
PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas
API referenceFor AI assistants

Trial · NCT03013491

Participant flow114

How many started, completed or left each group, period by period.

1 to 20 of 114

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Main StudySTARTEDCX-072 0.03 mg/kg (Part A and Part A2)2
Main StudySTARTEDCX-072 0.1 mg/kg (Part A and Part A2)2
Main StudySTARTEDCX-072 0.3 mg/kg (Part A and Part A2)8
Main StudySTARTEDCX-072 1 mg/kg (Part A and Part A2)9
Main StudySTARTEDCX-072 3 mg/kg (Part A and Part A2)13
Main StudySTARTEDCX-072 10 mg/kg (Part A and Part A2)16
Main StudySTARTEDCX-072 30 mg/kg (Part A and Part A2)3
Main StudySTARTEDCX-072 0.3 mg/kg + Ipilimumab 3 mg/kg (Part B1)6
Main StudySTARTEDCX-072 1 mg/kg + Ipilimumab 3 mg/kg (Part B1)3
Main StudySTARTEDCX-072 3 mg/kg + Ipilimumab 3 mg/kg (Part B1)3
Main StudySTARTEDCX-072 10 mg/kg + Ipilimumab 3 mg/kg (Part B1)8
Main StudySTARTEDCX-072 10 mg/kg + Ipilimumab 6 mg/kg (Part B1)6
Main StudySTARTEDCX-072 10 mg/kg + Ipilimumab 10 mg/kg (Part B1)1
Main StudySTARTEDCX-072 3 mg/kg + Ipilimumab 3 mg/kg (Part B2)6
Main StudySTARTEDCX-072 10 mg/kg + Ipilimumab 3 mg/kg (Part B2)1
Main StudySTARTEDCX-072 1 mg/kg + Vemurafenib 960 mg (Part C)3
Main StudySTARTEDCX-072 3 mg/kg + Vemurafenib 960 mg (Part C)6
Main StudySTARTEDCX-072 10 mg/kg + Vemurafenib 960 mg (Part C)2
Main StudySTARTEDCX-072 10 mg/kg (Part D)98
Main StudyCOMPLETEDCX-072 0.03 mg/kg (Part A and Part A2)0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03013491/flow

API referenceFor AI assistants